HALO News and Press, Halozyme Therapeutics Inc. From 09/15/21

Halozyme to Participate in the 2021 Cantor Virtual Global Healthcare Conference PR Newswire SAN DIEGO , Sept. 15, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun , senior vice president and chief financial ...

Fundamental Research Corp has issued a report entitled "Halo Collective Inc.(NEO: HALO / OTCQX: HCANF / GERMANY: A9KN) Q2 Revenue up 74% YoY / Spin-Off Transaction to Be a Catalyst" and dated August 27, 2021. To read a summary of the key highlights, or to login and download the full analyst r...

Halozyme to Present at Wells Fargo 2021 Virtual Healthcare Conference PR Newswire SAN DIEGO , Aug. 26, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley , president and chief executive officer, will pre...

The following slide deck was published by Halozyme Therapeutics, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Halozyme Therapeutics, Inc. 2021 Q2 - Results - Earnings Call Presentation

Image source: The Motley Fool. Halozyme Therapeutics, inc (NASDAQ: HALO) Q2 2021 Earnings Call Aug 9, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Halozyme Therapeutics, inc (HALO) Q2 2021 Earnings Call Transcrip...

Halozyme Therapeutics, Inc. (HALO) Q2 2021 Earnings Conference Call August 09, 2021, 04:30 PM ET Company Participants Al Kildani - Vice President of Investor Relations and Corporate Communications Helen Torley - President and CEO Elaine Sun - CFO Conference Call Participants Charles Duncan - ...

Halozyme Reports Second Quarter 2021 Results - Raising 2021 Revenue Guidance to $425-$445 Million from $375-$395 Million, GAAP Earnings Per Share Guidance to $1.55-$1.70 from $1.25-$1.40 and Non-GAAP Earnings per Share Guidance to $1.85-$2.00 from $1.55-$1.70 - - Second Quar...

Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference PR Newswire SAN DIEGO , July 30, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun , senior vice president and chief financial officer, wi...

Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call PR Newswire SAN DIEGO , July 27, 2021 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on ...

Halozyme Announces Janssen Receives U.S. FDA Approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) in Combination with Pomalidomide and Dexamethasone for Patients with Multiple Myeloma After First or Subsequent Relapse - Janssen's DARZALEX FASPRO® Now the F...